RxDoctor Payments Data

Brook Rogers, PA

Physician Assistant · Spanish Fork, UTNPI 1427308899

Payments from drug & device makers

$814in general payments, 2019–2025

Across 46 payments — averaging $17.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$187
  • Boehringer Ingelheim$172
  • AstraZeneca$142
  • Lilly USA, LLC$131
  • Biohaven Pharmaceutical Holding Company Ltd.$39
  • Pfizer$36
  • plus $108 from 5 others

What the payments were for

  • Food & beverage$814100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$814 in reported general payments places this provider in the 65th percentile of 1,543 physician assistant providers in Utah.

See all physician assistant providers in Utah

Medicare billing

Part B allowed, 2024
$2,770
Medicare patients
30
Services billed
57

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban371$216,217
JardianceEmpagliflozin237$139,501
XareltoRivaroxaban192$101,946
MounjaroTirzepatide92$97,685
TrulicityDulaglutide75$77,233
OzempicSemaglutide76$70,605
Synjardy XrEmpagliflozin/Metformin Hcl115$66,720
FarxigaDapagliflozin Propanediol86$48,755
TradjentaLinagliptin59$35,307
Trelegy ElliptaFluticasone/Umeclidin/Vilanter38$18,300
MyrbetriqMirabegron41$17,811
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr35$16,679
RybelsusSemaglutide32$16,542
Tresiba Flextouch U-200Insulin Degludec17$15,955
LinzessLinaclotide27$15,452

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta, Synjardy, Combivent Respimat$172$260,443446 claims
PfizerEliquis$36$216,217371 claims
Lilly USA, LLCMounjaro, Trulicity$131$174,917167 claims
Novo NordiskOzempic, Rybelsus$14$87,146108 claims
AstraZenecaFarxiga$142$48,75586 claims
AbbVieLinzess$187$15,45227 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,543 physician assistant providers in Utah.

Other physician assistant in Spanish Fork

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →